TY - JOUR
T1 - Local Anatomic Precursors to New-Onset Geographic Atrophy in Age-Related Macular Degeneration as Defined on OCT
AU - Age-Related Eye Disease Study 2 Ancillary Spectral-Domain Optical Coherence Tomography Study Group
AU - Pasricha, Malini Veerappan
AU - Tai, Vincent
AU - Sleiman, Karim
AU - Winter, Katrina
AU - Chiu, Stephanie J.
AU - Farsiu, Sina
AU - Stinnett, Sandra S.
AU - Lad, Eleonora M.
AU - Wong, Wai T.
AU - Chew, Emily Y.
AU - Toth, Cynthia A.
AU - McCall, Michelle
AU - Srivastava, Sunil
AU - Sarin, Neeru
AU - Schuman, Stefanie
AU - Sevilla, Monica
AU - Harrington, Christopher
AU - Gunther, Randall
AU - Tran-Viet, Du
AU - Folgar, Francisco
AU - Yuan, Eric
AU - Wong, Wai
AU - Hall, Katherine
AU - Chew, Emily
AU - Hwang, Thomas
AU - McCollum, Patti
AU - Hubbard, G. Baker
AU - Curtis, Linda
AU - Clemons, Traci
AU - Harrington, Molly
N1 - Funding Information:
The Age-Related Eye Disease Study 2 (AREDS2) study was supported by the intramural program funds and contracts from the National Eye Institute , National Institutes of Health , Bethesda, Maryland; the Department of Health and Human Services, Bethesda, Maryland (contract no.: HHS-N-260-2005-00007-C [ADB contract no. N01-EY-5-0007]). The following sponsors supported the AREDS2 Ancillary SD OCT Study with research grants and had no role in the design or conduct of this research: Genentech, San Francisco, California; Alcon, Fort Worth, Texas; and Bioptigen, Morrisville, North Carolina.
Publisher Copyright:
© 2020 American Academy of Ophthalmology
PY - 2021/5
Y1 - 2021/5
N2 - Purpose: In macula-wide analyses, spectral-domain (SD) optical coherence tomography (OCT) features including drusen volume, hyperreflective foci, and OCT-reflective drusen substructures independently predict geographic atrophy (GA) onset secondary to age-related macular degeneration (AMD). We sought to identify SD OCT features in the location of new GA before its onset. Design: Retrospective study. Participants: Age-Related Eye Disease Study 2 Ancillary SD OCT Study participants. Methods: We analyzed longitudinally captured SD OCT images and color photographs from 488 eyes of 488 participants with intermediate AMD at baseline. Sixty-two eyes with sufficient image quality demonstrated new-onset GA on color photographs during study years 2 through 7. The area of new-onset GA and one size-matched control region in the same eye were segmented separately, and corresponding spatial volumes on registered SD OCT images at the GA incident year and at 2, 3, and 4 years previously were defined. Differences in SD OCT features between paired precursor regions were evaluated through matched-pairs analyses. Main Outcome Measures: Localized SD OCT features 2 years before GA onset. Results: Compared with paired control regions, GA precursor regions at 2, 3, and 4 years before (n = 54, 33, and 25, respectively) showed greater drusen volume (P = 0.01, P = 0.003, and P = 0.003, respectively). At 2 and 3 years before GA onset, they were associated with the presence of hypertransmission (P < 0.001 and P = 0.03, respectively), hyperreflective foci (P < 0.001 and P = 0.045, respectively), OCT-reflective drusen substructures (P = 0.004 and P = 0.03, respectively), and loss or disruption of the photoreceptor zone, ellipsoid zone, and retinal pigment epithelium (RPE, P < 0.001 and P = 0.005–0.045, respectively). At 4 years before GA onset, precursor regions were associated with photoreceptor zone thinning (P = 0.007) and interdigitation zone loss (P = 0.045). Conclusions: Evolution to GA is heralded by early local photoreceptor changes and drusen accumulation, detectable 4 years before GA onset. These precede other anatomic heralds such as RPE changes and drusen substructure emergence detectable 1 to 2 years before GA. This study thus identified earlier end points for GA as potential therapeutic targets in clinical trials.
AB - Purpose: In macula-wide analyses, spectral-domain (SD) optical coherence tomography (OCT) features including drusen volume, hyperreflective foci, and OCT-reflective drusen substructures independently predict geographic atrophy (GA) onset secondary to age-related macular degeneration (AMD). We sought to identify SD OCT features in the location of new GA before its onset. Design: Retrospective study. Participants: Age-Related Eye Disease Study 2 Ancillary SD OCT Study participants. Methods: We analyzed longitudinally captured SD OCT images and color photographs from 488 eyes of 488 participants with intermediate AMD at baseline. Sixty-two eyes with sufficient image quality demonstrated new-onset GA on color photographs during study years 2 through 7. The area of new-onset GA and one size-matched control region in the same eye were segmented separately, and corresponding spatial volumes on registered SD OCT images at the GA incident year and at 2, 3, and 4 years previously were defined. Differences in SD OCT features between paired precursor regions were evaluated through matched-pairs analyses. Main Outcome Measures: Localized SD OCT features 2 years before GA onset. Results: Compared with paired control regions, GA precursor regions at 2, 3, and 4 years before (n = 54, 33, and 25, respectively) showed greater drusen volume (P = 0.01, P = 0.003, and P = 0.003, respectively). At 2 and 3 years before GA onset, they were associated with the presence of hypertransmission (P < 0.001 and P = 0.03, respectively), hyperreflective foci (P < 0.001 and P = 0.045, respectively), OCT-reflective drusen substructures (P = 0.004 and P = 0.03, respectively), and loss or disruption of the photoreceptor zone, ellipsoid zone, and retinal pigment epithelium (RPE, P < 0.001 and P = 0.005–0.045, respectively). At 4 years before GA onset, precursor regions were associated with photoreceptor zone thinning (P = 0.007) and interdigitation zone loss (P = 0.045). Conclusions: Evolution to GA is heralded by early local photoreceptor changes and drusen accumulation, detectable 4 years before GA onset. These precede other anatomic heralds such as RPE changes and drusen substructure emergence detectable 1 to 2 years before GA. This study thus identified earlier end points for GA as potential therapeutic targets in clinical trials.
KW - Age-Related Eye Disease Study 2
KW - Age-related macular degeneration
KW - Geographic atrophy
KW - Localized precursors
KW - Spectral-domain OCT
UR - http://www.scopus.com/inward/record.url?scp=85104709073&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104709073&partnerID=8YFLogxK
U2 - 10.1016/j.oret.2020.12.010
DO - 10.1016/j.oret.2020.12.010
M3 - Article
C2 - 33348086
AN - SCOPUS:85104709073
SN - 2468-7219
VL - 5
SP - 396
EP - 408
JO - Ophthalmology Retina
JF - Ophthalmology Retina
IS - 5
ER -